US Patent Issued to BEIJING GREATWAY PHARMACEUTICAL TECHNOLOGY on Aug. 18 for "Compound for adjusting activity of NMDA receptor, and pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,620, issued on Aug. 18, was assigned to BEIJING GREATWAY PHARMACEUTICAL TECHNOLOGY Co. LTD. (Beijing).

"Compound for adjusting activity of NMDA receptor, and pharmaceutical composition and use thereof" was invented by Wei Gu (Beijing), Zhaoji Dong (Beijing) and Ruiluan Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound for adjusting the activity of an NMDA receptor, and a pharmaceutical composition and the use thereof. In particular, provided are a compound as represented by formula I, a pharmaceutically acceptable salt or ester, a stereoisomer, or a solvate thereof. The compound has the effect of enhancing the acti...